🇺🇸 FDA
Pipeline program

buprenorphine

P04279

Approved small_molecule terminated

Quick answer

buprenorphine for Hepatitis C, Chronic is a Approved program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Indivior Pharmaceuticals
Indication
Hepatitis C, Chronic
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials